The Indian Institute of Science (IISc) announces the launch of the Longevity India Initiative, a project focused on efforts to extend human 'healthspan' and tackle ageing-related challenges
Takeda, a leading pharmaceutical firm, declared that the US Food and Drug Administration (FDA) has granted approval for the subcutaneous administration of Entyvio (vedolizumab) as maintenance therapy in adults with moderately to severely active...
Evotec SE and Variant Bio, Inc. have agreed to work together to find the best treatment for fibrosis-related diseases. In organs like the liver and lungs, fibrosis is characterized by a marked and pathogenic accumulation of the tissue matrix and...
Healthcare requires customized financing, expertise, and collaborations says Ajay Banga, World Bank President. He stated that while and after COVID, money for healthcare rose; but, in order to make healthcare inexpensive and accessible to all...
Lexaria Bioscience Corp, a proprietary drug delivery technology, declares that a sanction has been received from an independent third-party ethics review board for human pilot study #2 (the "Study"), which examined GLP-1 medications and...
Compass Therapeutics, a biopharmaceutical firm, reported that the intial patient has been dosed in its stage 1 dose-escalation clinical preliminary of CTX-8371, a PD-1 x PD-L1 bispecific neutralizer, in patients with solid tumours. “Dosing the...
Cipla, a leading pharmaceutical firm will acquire the beauty care products and individual consideration circulation and marketing business of Ivia Beaute Pvt Ltd, including the brands Astaberry, Ikin and Bhimsaini, on an overall reason for...
In a significant leap forward for private healthcare practitioners, a revolutionary clinic management solution - Doc-Aid was launched in the city today.
New Delhi-based Varco Leg Care, the world’s first dedicated leg care brand, has raised a cumulative of US$ 0.5 Million (over INR 4.5 Cr) in seed funding, while doubling its valuation within a span of only 10 months
Glenmark Pharmaceuticals is in the process of pulling back 6,528 bottles of medication used for high blood pressure treatment from the American market due to issues with dissolution specifications, PTI reported citing the US Food and Drug Administrat
, CDSCO.jpg)
.jpg)